Home > Congressional Record > December 11, 2019 > House Section > Page H10122

December 11, 2019 - Issue: Vol. 165, No. 198 — Daily Edition116th Congress (2019 - 2020) - 1st Session

Entire Issue (PDF)Browse By Date

SENATE BILL REFERRED; Congressional Record Vol. 165, No. 198
(House of Representatives - December 11, 2019)

Text available as:

Formatting necessary for an accurate reading of this text may be shown by tags (e.g., <DELETED> or <BOLD>) or may be missing from this TXT display. For complete and accurate display of this text, see the PDF.


[Page H10122]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                          SENATE BILL REFERRED

  A bill of the Senate of the following title was taken from the 
Speaker's table and, under the rule, referred as follows:

       S. 2740. An act to amend the Federal Food, Drug, and 
     Cosmetic Act to clarify the regulatory framework with respect 
     to certain nonprescription drugs that are marketed without an 
     approved new drug application, and for other purposes; to the 
     Committee on Energy and Commerce.

                          ____________________